MedPath
HSA Approval

CLODERM SCALP APPLICATION 0.05%

SIN09156P

CLODERM SCALP APPLICATION 0.05%

CLODERM SCALP APPLICATION 0.05%

January 13, 1997

ZUELLIG PHARMA PTE. LTD.

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZUELLIG PHARMA PTE. LTD.
Licence HolderZUELLIG PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

LOTION

**RECOMMENDED DOSAGE :** Wash and dry affected area. Apply Cloderm Scalp Application sparingly to the affected areas and rub in once or twice daily as directed by your doctor or pharmacist. If symptoms persist please consult your doctor or pharmacist. This preparation is for the treatment of your current condition only. Do not allow use by any other person and dispose of unused material when your treatment is complete.

TOPICAL

Medical Information

**INDICATIONS :** Psoriasis and recalcitrant eczemas of the scalp. Clobetasol is a highly-active topical corticosteroid which is indicated for use in short courses for conditions which do not respond satisfactorily to less active steroids.

**CONTRAINDICATIONS :** Hypersensitivity to the preparation, infections of the scalp, dermatoses in children under one year of age including dermatitis.

D07AD01

clobetasol

Manufacturer Information

ZUELLIG PHARMA PTE. LTD.

HOE PHARMACEUTICALS SDN BHD

Active Ingredients

CLOBETASOL PROPIONATE EQV CLOBETASOL

0.05%

Clobetasol propionate

Documents

Package Inserts

Cloderm Scalp Application PI.pdf

Approved: September 13, 2022

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLODERM SCALP APPLICATION 0.05% - HSA Approval | MedPath